Structure-Activity Relationship of Niclosamide Derivatives

Area of Science:

• Medicinal Chemistry
• Oncology
• Drug Discovery

Background:

• Cancer remains a significant global health challenge, driving the need for novel therapeutic strategies.
• Niclosamide, an anthelmintic drug, has shown potential anticancer properties, making its derivatives attractive candidates.
• Optimization of existing drug scaffolds is a key approach in developing new cancer treatments.

Purpose of the Study:

• To synthesize and evaluate novel niclosamide derivatives for anticancer activity.
• To identify derivatives with potent cytotoxic effects against various human cancer cell lines.
• To assess the impact of these derivatives on key cancer-related pathways, including NF-κB and mitochondrial function.

Main Methods:

• Synthesis of a library of niclosamide derivatives.
• In vitro testing against a panel of human cancer cell lines (breast, prostate, cervical, leukemia).
• Assays to evaluate inhibition of nuclear factor-kappa B (NF-κB) signaling and mitochondrial transmembrane potential (MTP).

Main Results:

• N-(3,5-Bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide demonstrated significant cytotoxicity against HL-60 leukemia cells.
• 5-chloro-N-(2-chlorophenyl)-2-hydroxybenzamide was most effective in inhibiting NF-κB.
• 5-chloro-N-(3,5-difluorophenyl)-2-hydroxybenzamide showed the highest activity in the MTP assay.
• Two derivatives, 5-chloro-N-(2-chloro-4-(trifluoromethyl)phenyl)-2-hydroxybenzamide and 5-chloro-2-hydroxy-N-(4-hydroxyphenyl)benzamide, inhibited both HL-60 proliferation and NF-κB.

Conclusions:

• Several synthesized niclosamide derivatives exhibit promising anticancer properties.
• Specific derivatives show targeted activity against cancer cell proliferation and key signaling pathways.
• Further in-depth studies are recommended to develop these active derivatives into potential anticancer therapeutics.